Search clinical trials for: unexplained thrombotic microangiopathy

Total 1116 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune Markers

Purpura, Thrombocytopenic, Idiopathic | Immune Thrombocytopenic Purpura

United States
Novartis

Completed

Efficacy and Safety of Lumiracoxib 400 mg in Arthroscopic Knee Surgery

Pain

Germany
Fredericia Hosptial

Completed

Pharmacological Modulation of the Intrarenal Pressure During Endourological Procedures in the Upper Urinary Tract

Kidney Stone | Unexplained Haematuria | Benignant Tumour Mass in the Upper Urinary Tract

Denmark
Hamilton Health Sciences Corporation
GlaxoSmithKline

Unknown

Fondaparinux to Prevent Thrombotic Complications and Graft Failure in Patients Undergoing Coronary Artery Bypass Graft Surgery: The Fonda CABG Study (Fonda CABG)

Coronary Bypass Graft Failure/Occlusion

Canada
Rambam Health Care Campus

Unknown

Hypercoagulable Parameters as Predictors of Thrombotic Events and Prognosis in Patients With Advanced Non-Small Cell Lung Carcinoma

Venous Thromboembolism | Non-Small Cell Lung Carcinoma

Israel
University Magna Graecia

Completed

Perifollicular Vascularity Assessment in in-Vitro Fertilization

Infertility

Italy
Isifer AB
Karolinska Institutet

Completed

A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility

Infertility

Sweden
University Hospital, Angers
Ministry of Health, France

Unknown

Cohort of Children With Acute Immune or Idiopathic Thrombocytopenic Purpura (ITP) : a Prospective Study in Pays De La Loire

Acute Idiopathic Thrombocytopenic Purpura

France
Prothya Biosolutions

Completed

Efficacy and Safety of IVIG-L in ITP Patients

Purpura, Thrombocytopenic, Idiopathic

Poland
Millennium Pharmaceuticals, Inc.

Completed

PROTECT-TIMI 30 Trial

Unstable Angina
Assistance Publique - Hôpitaux de Paris
Etablissement Français du Sang

Terminated

Study of the Effectiveness of Rituximab in Adults With Chronic and Severe Immune Thrombocytopenic Purpura and Candidate for a Splenectomy

Autoimmune Thrombocytopenic Purpura

France
University Hospital, Angers

Terminated

Effect of Chronic Oral Hydration in Patients With Recurrent Unexplained Syncope

Loss of Consciousness | Hydration | Neurocardiogenic Syncope
Glaxo Wellcome

Completed

An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral Pentamidine

HIV Infections | Pneumonia, Pneumocystis Carinii

United States
Genentech, Inc.

Completed

A Phase I Study of Recombinant Human CD4 Immunoglobulin G (rCD4-lgG) in Patients With HIV-Associated Immune Thrombocytopenic Purpura

HIV Infections | Immune Thrombocytopenic Purpura ( ITP )

United States
Fairview University Medical Center

Unknown

Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases

Rheumatoid Arthritis | Systemic Lupus Erythematosus | Giant Cell Arteritis | Wegener's Granulomatosis | Churg-Strauss Syndrome | Polyarteritis Nodosa | Purpura, Schoenlein-Henoch | Juvenile Rheumatoid Arthritis | Takayasu Arteritis | Pure Red Cell Aplasia | Graft Versus Host Disease | Anemia, Hemolytic, Autoimmune and other conditions

United States
Hematology and Oncology Specialists

Unknown

Study of Doxil in the Treatment of Patients With Refractory Idiopathic Thrombocytopenic Purpura

Autoimmune Thrombocytopenic Purpura

United States

Search clinical trials for: unexplained thrombotic microangiopathy

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations